The Pharma Letter10 天
Petosemtamab granted 2nd Breakthrough Therapy designation by FDA
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to Dutch clinical-stage drug ...
manilatimes11 天
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive ...
BTD designation follows the initial receipt of BTD and Fast Track designation for petosemtamab for the treatment of patients with r/m HNSCC whose disease has progressed following treatment with ...